These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 4398186

  • 1. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T, Rowles G, Shropshire AT, Gluckman MI.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract] [Full Text] [Related]

  • 2. Cardiovascular effects of prinodolol (LB-46), a potent beta-adrenergic receptor antagonist.
    Levy JV.
    J Clin Pharmacol New Drugs; 1971 Feb; 11(4):249-60. PubMed ID: 4397374
    [No Abstract] [Full Text] [Related]

  • 3. Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197).
    Privitera PJ, Blickenstaff T, Gaffney TE, Mohammed S.
    J Pharmacol Exp Ther; 1971 Mar; 176(3):655-61. PubMed ID: 4398744
    [No Abstract] [Full Text] [Related]

  • 4. Pulmonary vascular and cardiac effects of glucagon before and after adrenergic beta-receptor blockade.
    Madan BR, Gupta RS, Jain BK.
    Indian J Physiol Pharmacol; 1971 Oct; 15(4):173-7. PubMed ID: 4401547
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R, Miragoli G, Croce G.
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract] [Full Text] [Related]

  • 6. [Arrhythmia action and cardiovascular effects of a new beta-adrenergic blockader (Oxprenolol)].
    Suzuki K, Kubota M, Odashiro M, Yasuda K, Goto Y.
    Masui; 1972 Jan; 21(1):46-50. PubMed ID: 4401935
    [No Abstract] [Full Text] [Related]

  • 7. The cardiovascular pharmacology of bunolol, a new beta adrenergic blocking agent.
    Robson RD, Kaplan HR.
    J Pharmacol Exp Ther; 1970 Oct; 175(1):157-67. PubMed ID: 4394301
    [No Abstract] [Full Text] [Related]

  • 8. [Analysis of the concentration-effect curves for the action of isoproterenol on the trachea of guinea pigs pretreated with beta-adrenergic blocking agents].
    Otorii T.
    Nihon Heikatsukin Gakkai Zasshi; 1969 Jun; 5(2):76-83. PubMed ID: 4402317
    [No Abstract] [Full Text] [Related]

  • 9. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R, Delaunois G, Bauthier J.
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
    Lish PM, Weikel JH, Dungan KW.
    J Pharmacol Exp Ther; 1965 Aug; 149(2):161-73. PubMed ID: 4378558
    [No Abstract] [Full Text] [Related]

  • 11. [Evaluation of adrenergic beta receptor blockaders on the circulation in cats].
    Greeff K, Köhler E.
    Naunyn Schmiedebergs Arch Pharmakol; 1971 Aug; 270(1):79-86. PubMed ID: 4397216
    [No Abstract] [Full Text] [Related]

  • 12. Trasicor: review of the pharmacology and clinical results.
    Fuccella LM.
    S Afr Med J; 1969 Dec 06; ():Suppl:7-14. PubMed ID: 4190429
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.
    Stanton HC, Kirchgessner T, Parmenter K.
    J Pharmacol Exp Ther; 1965 Aug 06; 149(2):174-82. PubMed ID: 4378559
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol.
    Levy B.
    J Pharmacol Exp Ther; 1967 Jun 06; 156(3):452-62. PubMed ID: 6067476
    [No Abstract] [Full Text] [Related]

  • 15. Intrinsic sympathomimetic activity in relation to the precipitation of heart failure by beta-adrenoceptive blockade.
    Barrett AM, Nunn B.
    Arch Int Pharmacodyn Ther; 1971 Jan 06; 189(1):168-74. PubMed ID: 4399747
    [No Abstract] [Full Text] [Related]

  • 16. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG, Tay J.
    J Pharmacol Exp Ther; 1972 Feb 06; 180(2):302-16. PubMed ID: 4400889
    [No Abstract] [Full Text] [Related]

  • 17. [Pharmacological study of a new beta adrenergic inhibitor (S 2395)].
    Laubie M, Schmitt H, Mouillé P, Cheymol G, Gilbert JC.
    C R Acad Hebd Seances Acad Sci D; 1971 Oct 04; 273(14):1234-6. PubMed ID: 4399407
    [No Abstract] [Full Text] [Related]

  • 18. The adrenergic blocking activity of N-tert.-butylmethoxamine (butoxamine).
    Levy B.
    J Pharmacol Exp Ther; 1966 Mar 04; 151(3):413-22. PubMed ID: 4380047
    [No Abstract] [Full Text] [Related]

  • 19. Effects of -adrenoreceptor blocking drugs on isolated skeletal and cardiac muscle.
    Harry JD, Linden RJ, Snow HM.
    Br J Pharmacol; 1971 Oct 04; 43(2):453P-454P. PubMed ID: 4400575
    [No Abstract] [Full Text] [Related]

  • 20. Effects of beta-adrenoceptor blocking drugs on the chronotropic and inotropic actions of isoprenaline on the acutely denervated dog heart.
    Harry JD, Kappagoda CT, Linden RJ, Snow HM.
    Br J Pharmacol; 1971 Feb 04; 41(2):387P-389P. PubMed ID: 4396704
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.